Overlapping features of therapy-related and de novo NPM1-mutated AML

Othman, J; Meggendorfer, M; Tiacci, E; Thiede, C; Schlenk, R; Dillon, R; Stasik, S; Venanzi, A; Bertoli, S; Delabesse, E; Dumas, PY; Pigneux, A; Bidet, A; Gilkes, AF; Thomas, I; Voso, MT; Rambaldi, A; Brunetti, L; Perriello, VM; Andresen, V; Gjertsen, BT; Martelli, MP; Récher, C; Röllig, C; Bornhäuser, M; Serve, H; Müller-Tidow, C; Baldus, CD; Haferlach, T; Russell, N; Falini, B

Falini, B (通讯作者),Univ Perugia, Sect Hematol, Dept Med & Surg, Piazzale Menghini, I-06132 Perugia, Italy.;Falini, B (通讯作者),Santa Maria Misericordia Hosp, Ctr Hemato Oncol Res CREO, Piazzale Menghini, I-06132 Perugia, Italy.

BLOOD, 2023; 141 (15): 1846

Abstract

NPM1-mutated acute myeloid leukemia (AML) shows unique features. However, the characteristics of therapy-related NPM1-mutated AML (t-NPM1 AML) are poo......

Full Text Link